Literature DB >> 18584759

Conversion of alpha-ketoglutarate into L-glutamic acid with urea as ammonium source using multienzyme systems and dextran-NAD+ immobilized by microencapsulation within artificial cells in a bioreactor.

K F Gu1, T M Chang.   

Abstract

Urea could be effectively converted into L-glutamic acid with semipermeable nylon-polyethylenimine artificial cells containing L-glutamic dehydrogenase (EC 1.4.1. 3), yeast alcohol dehydrogenase (EC 1.1.1.1), urease (EC 3.5.1. 5) and soluble dextran-NAD(+). For batch conversion, the artificial cell suspension to total reaction volume ratios ranged from 1 in 5 to 1 in 60. From 22.6 to 53.4 micromol of L-glutamic acid could be produced by 0.4 mL artificial cell suspension within 2 h. The corresponding conversion ratios were 56.5-11. 1%. The L-glutamic dehydrogenase multienzyme system showed a good storage stability: 66.0% of the original activity was retained after 1 month of storage at 4 degrees C. A small bioreactor was prepared to contain 4.0 mL artificial cells. At a flow rate of SV = 1.5 h(-1), the maximum conversion rate was 49.6 micromol L-glutamic acid/p h. Thirty-eight percent of the maximum activity was retained when continuously used for four days at 22 degrees C. A kinetic analysis for the L-glutamic dehydrogenase multienzyme system was studied. The Michaelis constants are as follows: alpha-ketoglutarate is 0.838 mM; urea is 1.90 mM; dextran- NAD(+) is 0.345 mM; and ethanol is 5.31 mM.

Entities:  

Year:  1988        PMID: 18584759     DOI: 10.1002/bit.260320315

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  3 in total

1.  Conversion of ammonia or urea into essential amino acids, L-leucine, L-valine, and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD. L-lactic dehydrogenase for coenzyme recycling.

Authors:  K F Gu; T M Chang
Journal:  Appl Biochem Biotechnol       Date:  1990-11       Impact factor: 2.926

2.  Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.

Authors:  Razek Coussa; Christopher Martoni; Jasmine Bhathena; Aleksandra Malgorzata Urbanska; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2010-07-27

3.  Potentials and limitations of microorganisms as renal failure biotherapeutics.

Authors:  Poonam Jain; Sapna Shah; Razek Coussa; Satya Prakash
Journal:  Biologics       Date:  2009-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.